Insulet's maiden buy expands diabetes offering and grows customer base over three-fold
This article was originally published in Clinica
Marking its first acquisition since it went public in 2007, Insulet has bought Neighborhood Diabetes, a US distributor of diabetes supplies, for $63m. The move not only significantly expands Insulet's customer base in the US, increasing it from around 25,000 to 85,000, it also broadens the company's current offering beyond its flagship product, the OmniPod insulin pump, and consolidates its position in the diabetes market.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.